Innovative Biologics

Anti-infective drug discovery and development company targeting microbes that produce pore-forming toxins.

Launch date

2003

Employees

Market cap

Enterprise valuation

Herndon Virginia (HQ)

Date	Investors	Amount	Round
-	Small Business Innovation Research (SBIR)	N/A	-
Jan 2004	US Department of Health and Human Services	$1.7m	Grant
Oct 2007	CIT GAP Funds	$100k	Seed
Mar 2008	Johnson & Johnson Innovation Virginia Innovation Partnership Corporation	$200k	Early VC
Jul 2008	National Institutes of Health	$1.8m	Grant
Jan 2009	US Department of Health and Human Services	$2.3m	Grant
Total Funding		CAD8.3m

Recent News about Innovative Biologics